Copyright
©2010 Baishideng Publishing Group Co.
World J Stem Cells. Aug 26, 2010; 2(4): 67-80
Published online Aug 26, 2010. doi: 10.4252/wjsc.v2.i4.67
Published online Aug 26, 2010. doi: 10.4252/wjsc.v2.i4.67
Indications | Source | Rout of administration | Outcome |
Myocardial infarction | Allogenic BM | IV | Increased GSS and EF[148] |
Autologous BM | Intracoronary | Improved LVF[149] | |
Cartilage defect | Autologous BM | Direct site transplantation | Improved clinical symptom and coverage of defect[110] |
Osteogenesis imperfecta | Allogenic BM | IV | Growth acceleration[117] |
Fetal MSC | Intrauterine transplantation | Osteoblastic differentiation and reduced fracture[119] | |
Critical size defect | Autologous BM | Scaffold loaded | Faster full recovery of limb function than bone graft[103] |
MLD and hurler syndrome | Allogenic BM | IV | Improved nerve conduction velocity in MLD patient and increased bone mineral density[167] |
Severe idiopathic aplastic anemia | Allogenic BM | IV | Improved stroma[168] |
Crohn's disease | Adipose derived stem cell | Intralesional | Improved fistula and quality of life[136] |
- Citation: Rastegar F, Shenaq D, Huang J, Zhang W, Zhang BQ, He BC, Chen L, Zuo GW, Luo Q, Shi Q, Wagner ER, Huang E, Gao Y, Gao JL, Kim SH, Zhou JZ, Bi Y, Su Y, Zhu G, Luo J, Luo X, Qin J, Reid RR, Luu HH, Haydon RC, Deng ZL, He TC. Mesenchymal stem cells: Molecular characteristics and clinical applications. World J Stem Cells 2010; 2(4): 67-80
- URL: https://www.wjgnet.com/1948-0210/full/v2/i4/67.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v2.i4.67